Anika Therapeutics, Inc. Inventory, Finished Goods, Net of Reserves
Anika Therapeutics, Inc. (ANIK) had Inventory, Finished Goods, Net of Reserves of $5.48 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Notes › Inventory, Net, Items Net of Reserve Alternative › Inventory, Finished Goods and Work in Process, Net of Reserves
us-gaap:InventoryFinishedGoodsNetOfReserves · last filed 2026-07-29
- 2026-06-30: Inventory, Finished Goods, Net of Reserves $5.48M.
- 2026-03-31: Inventory, Finished Goods, Net of Reserves $4.59M.
- 2025-12-31: Inventory, Finished Goods, Net of Reserves $3.51M.
- 2025-09-30: Inventory, Finished Goods, Net of Reserves $4.48M.
| Period end | Inventory, Finished Goods, Net of Reserves | Inventory, Finished Goods, Net of Reserves as first filed |
|---|---|---|
| 2026-06-30 | $5.48M 10-Q · filed 2026-07-29 | |
| 2026-03-31 | $4.59M 10-Q · filed 2026-04-30 | |
| 2025-12-31 | $3.51M 10-Q · filed 2026-07-29 | |
| 2025-09-30 | $4.48M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $4.53M 10-Q · filed 2025-07-30 | |
| 2025-03-31 | $6.43M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $8.76M 10-K · filed 2026-03-03 | |
| 2024-09-30 | $17.53M 10-Q · filed 2024-11-04 | |
| 2024-06-30 | $38.23M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $33.05M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $7.71M 10-K · filed 2025-03-17 | $32.08M 10-K · filed 2024-03-15 |
| 2023-09-30 | $28.56M 10-Q · filed 2023-11-03 | |
| 2023-06-30 | $26.25M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $24.95M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $25.31M 10-K · filed 2024-03-15 | |
| 2022-09-30 | $24.28M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $24.58M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $24.26M 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $26.73M 10-K · filed 2023-03-16 | |
| 2021-09-30 | $28.93M 10-Q · filed 2021-11-05 | |
| 2021-06-30 | $33.88M 10-Q · filed 2021-08-06 | |
| 2020-12-31 | $33.35M 10-K · filed 2022-03-11 | |
| 2020-09-30 | $35.26M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $33.68M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $35.34M 10-Q · filed 2021-05-07 | $37.31M 10-Q · filed 2020-05-22 |
| 2019-12-31 | $8.78M 10-K/A · filed 2021-04-26 | |
| 2019-09-30 | $10.23M 10-Q · filed 2019-10-28 | |
| 2019-06-30 | $8.75M 10-Q · filed 2019-07-26 | |
| 2019-03-31 | $7.54M 10-Q · filed 2019-05-06 | |
| 2018-12-31 | $6.82M 10-K · filed 2020-03-06 | |
| 2018-09-30 | $4.64M 10-Q · filed 2018-10-26 | |
| 2018-06-30 | $5.16M 10-Q · filed 2018-07-31 | |
| 2018-03-31 | $6.81M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $4.68M 10-K · filed 2019-02-27 | |
| 2017-09-30 | $5.82M 10-Q · filed 2017-10-27 | |
| 2017-06-30 | $4.83M 10-Q · filed 2017-07-28 | |
| 2017-03-31 | $4.66M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $4.54M 10-K · filed 2018-02-27 | |
| 2016-09-30 | $6.34M 10-Q · filed 2016-11-01 | |
| 2016-06-30 | $4.31M 10-Q · filed 2016-08-01 | |
| 2016-03-31 | $4.06M 10-Q · filed 2016-05-03 | |
| 2015-12-31 | $3.50M 10-K · filed 2017-02-24 | |
| 2015-09-30 | $3.29M 10-Q · filed 2015-11-03 | |
| 2015-06-30 | $3.14M 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $3.13M 10-Q · filed 2015-05-04 | |
| 2014-12-31 | $3.20M 10-K · filed 2016-03-10 | $3.20M 10-K · filed 2015-03-13 |
| 2013-12-31 | $2.76M 10-K · filed 2015-03-13 | |
| 2012-12-31 | $1.40M 10-K · filed 2014-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |